US / Johnson & Johnson Johnson & Johnson Sees $5.5B End to Its Headache Deal would settle nearly 80K claims linking talc-based powder to ovarian cancer By Arden Dier withNewser.AI Posted Jul 28, 2026 8:30 AM CDT Copied Back